Spooked AbbVie investors are selling off shares—but do they need to be?
admin 20th July 2018 Uncategorised 0AbbVie investors are running for the exits after comments on biosimilars from the FDA head, proposed rebate rule changes from the Trump administration and an ominous short-seller tweet. But they don’t need to be, industry watchers say.
More: Spooked AbbVie investors are selling off shares—but do they need to be?
Source: fierce